Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNT1 | O60563 | 2/20 | 0.32 |
| ▸ | CCNK | O75909 | 2/20 | 0.32 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.32 |
| ▸ | CDK2 | P24941 | 2/20 | 0.32 |
| ▸ | CDK9 | P50750 | 2/20 | 0.32 |
| ▸ | CDK12 | Q9NYV4 | 2/20 | 0.32 |
| ▸ | CDK7 | P50613 | 3/20 | 0.32 |
| ▸ | CCNH | P51946 | 3/20 | 0.32 |
| ▸ | MNAT1 | P51948 | 3/20 | 0.32 |
| ▸ | NFATC1 | O95644 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30716336 | 1.00 | CCNT1 (0.32) | CCNT1CCNKCCNE1CDK2CDK9 | |
| SCHEMBL30716329 | 0.81 | CLK1 (0.42) | CCNT1CCNKCCNE1CDK2CDK9 | |
| SCHEMBL30716225 | 0.73 | RPS6KA5 (0.38) | CCNT1CCNKCCNE1CDK2CDK9 | |
| SCHEMBL26696831 | 0.73 | RPS6KA5 (0.38) | CCNT1CCNKCCNE1CDK2CDK9 | |
| SCHEMBL28817278 | 0.70 | CCNT1 (0.43) | CCNT1CCNKCCNE1CDK2CDK9 | |
| SCHEMBL30007128 | 0.70 | CCNT1 (0.43) | CCNT1CCNKCCNE1CDK2CDK9 | |
| SCHEMBL30359906 | 0.70 | PIN1 (0.43) | CCNT1CCNKCCNE1CDK2CDK9 | |
| SCHEMBL22076269 | 0.69 | CCNK (0.48) | CCNT1CCNKCCNE1CDK2CDK9 | |
| SCHEMBL30006772 | 0.62 | AR (0.39) | CCNT1CCNKCCNE1CDK2CDK9 | |
| SCHEMBL28817288 | 0.62 | AR (0.39) | CCNT1CCNKCCNE1CDK2CDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023227125-A1 | NEW FUSED-HETEROCYCLIC COMPOUND AS CDK INHIBITOR AND USE THEREOF | 杭州德睿智药科技有限公司 | 2023-11-30 | — | — | WO | disclosed |